U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...

Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived ...

Tris Pharma’s opioid alternative has scored a third win in a trio of clinical trials, providing the biotech with the data ...

In just one weekend, a community rallies to make sure 8-year-old Gio Trotter can get to the Children's Hospital of ...

The results of the study indicate that certain clinical and genetic factors significantly influence therapy dropout. The ...

SaveHealth provides an overview of the different illnesses that typically come on with age, as well as treatment and ...

A new study on the use of medical marijuana by older patients—age 50 and above—concludes that “cannabis seemed to be a safe ...

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.

Netcare Akeso warns that the transition from using medications for their intended medical purpose to habitual use, dependency ...

LTG-001, a selective inhibitor for treatment of acute pain, was granted Fast Track designation by the Food and Drug Administration (FDA).